rly-4008
relay therapeutics
['rly-4008']
the #oncoalerttoptweet #esmo22 day 3 tweet rly-4008 a highly selective fgfr-2 inhibitor reached orr 82.4% in fgfr-2 fusions or rearrangement patients with #cholangiocarcinoma naive to fgfr2 inhibitors best 
?? Worldwide Network of Oncology Professionals & Patient Advocates with the common goal of ending cancer, we are Oncology360 degrees ?? We are #OncoAlert ??